INTRODUCTION
increase and protein kinase C (PKC) stimulation. 20, 21 PLCγ2 activation is essential for integrin α2β1-mediated spreading, as well as for the cross-talk to integrin αIIbβ3. 20, 21 It has also been shown that integrin α2β1 stimulates tyrosine kinases, including Src and Syk, as well as small GTPases, like Rac and Rap1b. [20] [21] [22] [23] [24] Based on the observation that the PI3K inhibitor wortmannin affects some platelet responses, 22 ,23 the stimulation of PI3K by integrin α2β1 has been hypothesized, but so far this has not been directly demonstrated.
In this study, we adopted pharmacologic and genetic approaches to investigate the regulation and function of PI3K in integrin α2β1-mediated adhesion of human and murine platelets. We demonstrate that integrin α2β1 selectively stimulates PI3Kβ isoform through a novel mechanism that involves intracellular Ca 2+ and the Ca 2+ -regulated tyrosine kinase Pyk2.
Moreover, we also provide evidence that PI3Kβ is dispensable for integrin α2β1-mediated platelet spreading on collagen, but is required for the inside-out activation of integrin αIIbβ3.
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From 7 acquired. The number of adherent cells, as well as the average cell area (as an index of platelet spreading), was determined using the ImageJ software. For each specimen, five different fields were analysed by two independent observers.
Rap1 activation assay
Analysis of accumulation of active GTP-bound Rap1b in adherent platelets was performed by a pull-down assay, using the glutathione S-transferase-tagged Rap-binding domain of RalGDS, essentially as previously described.
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Electrophoresis and immunoblotting
Aliquots of platelet lysates containing the same amount of proteins were dissociated by addition of 0.5 volumes of SDS-sample buffer 3X (37.5 mM Tris, 288 mM glycine, pH 8.3, 6% SDS, 1.5% DTT, 30% glycerol, 0.03% bromophenol blue), and samples were heated at 95°C for 3 minutes. SDS-sample buffer 2X was also added to precipitated, active Rap1b.
Proteins were separated by SDS-PAGE, typically on a 10% acrylamide gel for the analysis of Akt or Pyk2 phosphorylation, or on a 10-20% acrylamide gradient gel for Rap1b detection, and subsequently transferred to PVDF membrane. Membranes were blocked for 2 hours with 5% BSA in Tris buffer saline (20 mM Tris/HCl, pH 7.5, 0.5 mM NaCl), and then incubated overnight at 4°C with the desired primary antibodies diluted in 20 mM Tris/HCl, pH 7.5, 0.5 mM NaCl. In the present study the following antibodies and dilution were used: antiphosphoAkt(Ser473), 1:500; anti-phosphoPyk2(Tyr402), 1:500; anti-pleckstrin, 1:1000; antitubulin, 1:1000; anti-Pyk2, 1:500; anti FAK, 1:200, anti-Rap1, 1:1000. Membranes were then extensively washed with 0.1% Tween 20 in Tris buffer saline, and incubated with peroxidaseconjugated secondary antibody (1:3000 dilution) for 45 minutes. Upon extensive washing, reactive proteins were visualized with a chemiluminescence reaction. The PVDF membranes were then stripped and reprobed with a different antibody (typically, anti-tubulin or antipleckstrin) as a control for equal loading. All the immunoblots reported in this manuscript are representative of at least three different experiments giving similar results. Quantification of protein intensity was performed by computer assisted densitometric scanning using image J software.
Thrombus formation under flow
Glass coverslips were coated with monomeric type I collagen (100 μg/ml), and blocked with 1% BSA in PBS pH 7.4. The coverslips were mounted in a 50 μ m-deep parallel- 5.5 mM glucose, 0,1% BSA, 1 U/ml heparin). PPACK/heparin-treated mouse blood was preincubated with 3 μ g/ml CFSE for 5 minutes, and flowed over collagen at 1,000 sec −1 for 4 minutes, using a pump system (Harvard Apparatus PHD 2000). Upon perfusion, the flow chamber was rinsed with washing buffer, and at least 10 randomly taken fluorescence microscopic images were collected after 2 minutes and 10 minutes of rinse. Images were analyzed by ImageJ software, and the extent of thrombus formation was calculated as the percentage of platelet covered area.
Measurement of fibrinogen binding to collagen adherent platelets
Measurement and quantification of specific binding of biotin-labeled fibrinogen to integrin αIIbβ3 in platelets adherent through integrin α2β1 was performed according to a procedure that integrates data from multiple determination, as previously described in details. 21 This procedure allows the calculation of the specific binding of fibrinogen for the same number of adherent cells.
RESULTS
Integrin α2β1 activates PI3Kβ.
We have previously reported that PI3Kβ is essential for GPVI-mediated platelet activation, and is required for platelet spreading on fibrinogen. 4 Here we investigated the activation of PI3K upon platelet adhesion through integrin α2β1, by measuring the phosphorylation of the downstream effector Akt. Washed human platelets were allowed to adhere to immobilized monomeric type I collagen, or to GFOGER peptide in the presence of 2 mM MgCl 2 for increasing times. We have previously demonstrated that, under the conditions of this assay, monomeric type I collagen promotes platelet adhesion exclusively through integrin α2β1 and does not lead to GPVI stimulation. 4, 24, 29 GFOGER peptide is a well characterized specific ligand for integrin α2β1. 30 Adherent platelets were lysed, and Akt phosphorylation on Ser473 was evaluated by immunoblotting with a phosphospecific antibody. Figure 1A shows that engagement of integrin α2β1 by monomeric collagen or by GFOGER peptide induced a robust time-dependent phosphorylation of Akt. To identify the PI3K isoform involved, platelets were incubated with inhibitors of different PI3K isoforms before adhesion to monomeric type I collagen. Figure 1B shows that integrin α2β1-induced is still unknown. Using a phospho-specific antibody able to detect Pyk2 autophosphorylation on Tyr402, we evaluated the activation of this kinase in platelets adherent to monomeric collagen or to GFOGER peptide. Figure 3A shows that integrin α2β1 promoted the timedependent activation and autophosphorylation of Pyk2. Activation of Pyk2 did not require PI3K activity, as it occurred normally in the PI3Kβ KD platelets (figure 3B), but was regulated by intracellular Ca
2+
, because it was inhibited by BAPTA-AM, and upon blockade of IP 3 -mediated Ca 2+ release by 2-APB ( figure 3C ). Importantly, integrin α2β1-induced activation of Pyk2 was completely dependent on PLCγ2, as it failed to occur in PLCγ2-deficient platelets ( figure 3D ). Therefore, as for PI3Kβ, also Pyk2 activation is downstream of PLCγ2 and cytosolic Ca PI3Kβ is required for the cross-talk between integrin α2β1 and integrin αIIbβ3.
We next addressed the question as to the functional relevance of the Pyk2/PI3Kβ pathway in platelet adhesion through integrin α2β1.We have previously shown that PI3Kβ is required for platelet spreading on fibrinogen. 4 By contrast, we failed to detect any significant difference in platelets adhesion or spreading mediated by integrin α2β1 between wild type and PI3Kβ KD platelets ( figure 5A ). This observation was also supported by pharmacologic studies with specific inhibitors. As shown in figure 5B , integrin α2β1-mediated platelet adhesion and spreading was not affected by wortmannin, TGX-221 or AS252424. Similarly, no significant differences in integrin α2β1-mediated adhesion and spreading were detected between wild type and Pyk2 deficient platelets ( figure 5C ), indicating that, as for PI3Kβ, neither Pyk2 is required for these processes.
Platelet adhesion through integrin α2β1 leads to the inside-out activation of integrin αIIbβ3 through a signaling pathway that involves PLCγ2 and the small GTPase Rap1b.
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For personal use only. on October 22, 2017. by guest www.bloodjournal.org From Therefore, we investigated the contribution of Pyk2 and PI3Kβ on the cross-talk to integrin αIIbβ3. Figure 6A shows that adhesion-dependent activation of Rap1b was strongly reduced upon inhibition of PI3Kβ by wortmannin or TGX-221. Moreover, a similarly impaired Rap1b activation induced by integrin α2β1 was also observed in the Pyk2-deficient platelets.
Therefore, Pyk2 and PI3Kβ are important regulators of Rap1b activity downstream of integrin α2β1.
We next directly evaluated the inside-out activation of integrin αIIbβ3 by measuring the specific binding of fibrinogen to collagen-adherent platelets. Figure 6C shows that fibrinogen binding was strongly inhibited by wortmannin and by the specific PI3Kβ inhibitor TGX-221, and was also significantly reduced in the absence of Pyk2. Therefore, we conclude that Pyk2 and PI3Kβ play a role in the cross-talk between integrins α2β1and αIIbβ3.
Under flow conditions, activation of integrin αIIbβ3 in collagen adherent platelets is important for the growth and stabilization of the thrombus. Therefore, we analysed the role of Pyk2 and PI3Kβ in thrombus formation under flow. Fluorescently labeled platelets in whole blood were perfused for 4 minutes at a shear rate of 1,000 sec -1 over immobilized monomeric collagen, to favour integrin α2β1-initiated platelet adhesion and thrombus formation. The stability of the formed thrombus was then evaluated upon secondary perfusion with HEPES buffer for 10 minutes. Figure 7 shows that thrombus formation was strongly reduced when blood from either Pyk2-deficient or PI3Kβ KD mice were perfused. The defective thrombus formation was more evident in the absence of catalytically active PI3Kβ (89.28 ± 0.67 % of reduction of the covered area compared to control, n=4), than in the absence of Pyk2 (69.06 ± 7.27 % of reduction, n=4). After extensive perfusion of buffer we did not detect, under our experimental conditions, any significant reduction of the covered area by platelets from wild type and Pyk2 KO mice. A small, but significant reduction of the covered area was detected, however, in the absence of catalytically active PI3Kβ, which more likely reflects the detachment of adherent platelets, since basically no thrombi of relevant size were detected in these samples. These results indicate that perfusion of blood over monomeric collagen triggers the formation of stable platelet thrombi, supported by the Pyk2/PI3Kβ signaling pathway 
DISCUSSION
In this work we have investigated the role and the regulation of PI3K in platelet integrin α2β1 signaling. We have demonstrated that integrin α2β1 selectively stimulates PI3Kβ downstream of PLCγ2, through a mechanism that involves the Ca 2+ -dependent tyrosine kinase Pyk2. Moreover, we have described that PI3Kβ is not required for integrin α2β1-mediated spreading, but is important for the activation of the small GTPase Rap1b and for the cross-talk to integrin αIIbβ3, leading to fibrinogen binding to collagen-adherent platelets.
Although the role of integrin α2β1 in platelet adhesion to collagen, and its ability to trigger platelet activation are well documented, little is known about the outside-in signaling pathways activated by this integrin. For instance, the involvement of PI3K has been hypothesized based on indirect evidence with inhibitors, 22,23 but has never been directly documented. By measuring Akt phosphorylation we have filled this gap of information, as we have directly demonstrated the effective stimulation of PI3K by integrin α2β1, and we have also identified the isoform implicated.
Monomeric type I collagen has been mainly used in this work as a reliable, cheap, and easy to obtain ligand for integrin α2β1, because previous studies have clearly demonstrated that under these conditions no activation of GPVI occurs. 4, 24, 29 However, stimulation of PI3Kβ activity by integrin α2β1 was also confirmed using a different specific ligand, the collagen related peptide GFOGER. Moreover, although the majority of the experiments reported in this study were performed using type I monomeric collagen, as integrin α2β1
ligand, many of the results have been confirmed in experiments with the GFOGER peptide (data not shown).
By using a combination of pharmacologic and genetic approaches we have identified PI3Kβ as the PI3K isoform stimulated by integrin α2β1. Among all the members of the class I PI3K, PI3Kβ is emerging as a major regulator of platelet activation. We and others have previously shown that PI3Kβ is activated by GPVI, as well as by GPCRs, and is important for platelet spreading on fibrinogen. [3] [4] [5] [6] [7] The finding that PI3Kβ is also activated by integrin α2β1
further extends the role and importance of this isoform in platelet function. PI3Kβ is also In the experimental model adopted in this study, PLCγ2-dependent activation of PI3Kβ can be detected only after 30 minutes of adhesion, while these processes are supposed to occur within seconds in vivo. This consideration, that holds true also for a large number of other previous studies, clearly represents an intrinsic limitation in the investigation of the signaling processes associated to platelet adhesion, and the relevance of the experimental observations relies on the assumption that those events that in vitro need time to reach detectable levels, actually occurs much more rapidly under physiological conditions in vivo.
PI3Kβ is typically considered to be activated by receptor or non-receptor tyrosine kinases, which provide phosphotyrosine residues able to bind the SH2 domains of the regulatory subunit p85, thus relieving a constitutive inhibitory action on the p110β catalytic subunit. 1 In addition, PI3Kβ has been found to be also activated by G-proteins βγ dimers, and by the small GTPase Ras, through mechanisms that are not completely understood yet. 1 Generation of Pyk2-knockout mice allowed a better understanding of the role of this kinase in many physiological context, including macrophage migration and osteoclasts activation.
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A comprehensive and detailed analysis of platelet functions in Pyk2-knockout mice is described in a separated manuscript, which documents the importance of this kinase for platelet aggregation and thrombus formation (Canobbio et al, manuscript in preparation). In the present study, we report that Pyk2-deficient platelets show a defective activation of PI3Kβ upon integrin α2β1-mediated adhesion. A possible role for Pyk2 in the regulation of platelet PI3K activity has been previously hypothesized on the basis of some circumstantial evidence. 40 that Pyk2 plays a similar role also in humans. In the absence of any pathology associated to a deficiently of Pyk2, this assumption could only be confirmed pharmacologically. We have tested some commercially available Pyk2 inhibitors, but we have detected a number of nonspecific effects that precluded any further reliable investigation (data not shown).
In this work, we have also addressed the question as to the role of the Pyk2/PI3Kβ pathway in platelet adhesion through integrin α2β1. We have found that adhesion and spreading on monomeric collagen occurred normally in the absence of catalytically active PI3Kβ. Interestingly, we have previously shown that adhesion and spreading on immobilized fibrinogen was severely compromised in PI3Kβ KD platelets. 4 Therefore, it is clear that PI3Kβ plays different roles downstream of integrins α2β1 and αIIbβ3. This conclusion is not related to a difference in ligand density, which, for instance, has been shown to affect outside- CalDAG-GEFI leading to GTP-Rap1b accumulation. Whatever the mechanism, it is clear that the small GTPase Rap1b integrates many signaling pathways initiated by PLCγ2 in integrin α2β1-adherent platelets, and convey them to the inside-out activation of integrin αIIbβ3. A general scheme illustrating the role of PI3Kβ and Pyk2 the signaling pathway linking integrin α2β1 and integrin αIIbβ3 is depicted in supplemental figure 1.
In conclusion, our results identify a novel mechanism for PI3Kβ activation in integrin α2β1 outside-in signaling that depends on PLCγ2 and on the Ca For 
